Global economic burden of norovirus gastroenteritis

Sarah Bartsch, Benjamin A. Lopman, Sachiko Ozawa, Aron J. Hall, Bruce Lee

Research output: Contribution to journalArticle

Abstract

Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95% UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95% UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children

Original languageEnglish (US)
Article numbere0151219
JournalPLoS One
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Norovirus
gastroenteritis
Gastroenteritis
Economics
economics
Health
Costs
Public health
Pathogens
cost of illness analysis
Vaccines
Productivity
Cost of Illness
Ambulatory Care
Administrative Personnel
Health Care Costs
simulation models
public health
Hospitalization
Public Health

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Global economic burden of norovirus gastroenteritis. / Bartsch, Sarah; Lopman, Benjamin A.; Ozawa, Sachiko; Hall, Aron J.; Lee, Bruce.

In: PLoS One, Vol. 11, No. 4, e0151219, 01.04.2016.

Research output: Contribution to journalArticle

Bartsch, Sarah ; Lopman, Benjamin A. ; Ozawa, Sachiko ; Hall, Aron J. ; Lee, Bruce. / Global economic burden of norovirus gastroenteritis. In: PLoS One. 2016 ; Vol. 11, No. 4.
@article{9e8a4ca3a1504ef788d421a378ee6a00,
title = "Global economic burden of norovirus gastroenteritis",
abstract = "Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95{\%} UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95{\%} UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children",
author = "Sarah Bartsch and Lopman, {Benjamin A.} and Sachiko Ozawa and Hall, {Aron J.} and Bruce Lee",
year = "2016",
month = "4",
day = "1",
doi = "10.1371/journal.pone.0151219",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Global economic burden of norovirus gastroenteritis

AU - Bartsch, Sarah

AU - Lopman, Benjamin A.

AU - Ozawa, Sachiko

AU - Hall, Aron J.

AU - Lee, Bruce

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95% UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95% UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children

AB - Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95% UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95% UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children

UR - http://www.scopus.com/inward/record.url?scp=84964777959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964777959&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0151219

DO - 10.1371/journal.pone.0151219

M3 - Article

C2 - 27115736

AN - SCOPUS:84964777959

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e0151219

ER -